Pulmonary Disease Clinical Trial
— SLPvsPNTOfficial title:
Validation of Structured Light Plethysmography Against Spirometry in Children and Adults
NCT number | NCT02598336 |
Other study ID # | CIP01/0010 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2011 |
Est. completion date | September 2017 |
Verified date | July 2018 |
Source | Pneumacare Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Measurements of Structured Light Plethysmography (SLP) using a chest wall movement based
method will be compared to those obtained by spirometry using a flow based pneumotachograph
method. This study will enable validation of SLP in children and adults by allowing direct
comparison of simultaneous measurements of breathing sequences using the two measurement
techniques.
The investigators will also examine, in a group of normal adults, repeatability of the
agreement between the two devices, and whether the agreement is affected by a change in tidal
breathing parameters.
Status | Completed |
Enrollment | 41 |
Est. completion date | September 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 80 Years |
Eligibility |
Inclusion Criteria: - For the patient group, any patient attending the outpatient department or the Lung Function Laboratory - For the Healthy Normals group, any adult between 18 and 80 years with no current or previous respiratory condition. Exclusion Criteria: - A current cold or other viral infection - chest surgery within 4 weeks - Haemoptysis of unknown origin the (forced expiratory manoeuvre may aggravate the underlying condition) - Pneumothorax - Unstable respiratory or cardiovascular status (forced expiratory manoeuvre may worsen angina or cause changes in blood pressure) or recent myocardial infarction or pulmonary embolus - Recent eye surgery - Presence of an acute disease process that might interfere with test performance (e.g. Nausea, vomiting) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Cambridge University Hospitals Foundation Trust | Cambridge | Cambridgeshire |
Lead Sponsor | Collaborator |
---|---|
Pneumacare Ltd | Cambridge University Hospitals NHS Foundation Trust, University of Cambridge |
United Kingdom,
Bates JH, Schmalisch G, Filbrun D, Stocks J. Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000 Dec;16(6):1180-92. — View Citation
Cala SJ, Kenyon CM, Ferrigno G, Carnevali P, Aliverti A, Pedotti A, Macklem PT, Rochester DF. Chest wall and lung volume estimation by optical reflectance motion analysis. J Appl Physiol (1985). 1996 Dec;81(6):2680-9. — View Citation
Ferrigno G, Carnevali P, Aliverti A, Molteni F, Beulcke G, Pedotti A. Three-dimensional optical analysis of chest wall motion. J Appl Physiol (1985). 1994 Sep;77(3):1224-31. — View Citation
Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R; ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J. 2001 Feb;17(2):302-12. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Inspiratory over Expiratory flow at 50 percent of tidal displacement (IE50) expressed at a ratio | Flow ratios derived from the Respiratory Waveforms | 5 minutes | |
Primary | Forced Vital Capacity (FVC) measured in Litres | The volume of air a person can exhale during a maximal forced breath | 5 minutes | |
Primary | Forced Expiratory Volume in one second (FEV1) measured in litres per second | The volume of air a person can exhale in one second during a maximal forced breath | 5 minutes | |
Primary | Peak Expiratory Flow (PEF) measured in litres per second | The maximal flow a person can achieve during a maximal forced breath | 5 minutes | |
Secondary | Respiratory Waveform | Visual comparison of respiratory waveform shape and amplitude produced by pneumotachograph and SLP. | 5 minutes | |
Secondary | Respiratory Rate (RR) measured in seconds | Tmings derived from the Respiratory Waveforms | 5 minutes | |
Secondary | Inspiratory Time (tI) measured in seconds | Timings derived from the Respiratory Waveforms | 5 minutes | |
Secondary | Expiratory Time (tE) measured in seconds | Timings derived from the Respiratory Waveforms | 5 minutes | |
Secondary | Total breath time (tTot) measured in seconds | Timings derived from the Respiratory Waveforms | 5 minutes | |
Secondary | Inspiratory/expiratory ratio (tI/tE) expressed as a ratio | Timing ratios derived from the Respiratory Waveforms | 5 minutes | |
Secondary | The duty cycle (tI/tTot) expressed as a ratio | Timing ratios derived from the Respiratory Waveforms | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
Recruiting |
NCT06088485 -
The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
|
||
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Active, not recruiting |
NCT02504697 -
DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
|
||
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Terminated |
NCT00524095 -
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
|
Phase 2 | |
Completed |
NCT00210249 -
Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
|
||
Completed |
NCT00023114 -
p450 Mediated Lung Toxicity
|
N/A | |
Recruiting |
NCT06056882 -
Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
|
||
Completed |
NCT03994848 -
Incentive Spirometry Prehabilitation Study
|
N/A | |
Completed |
NCT00366509 -
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
|
||
Withdrawn |
NCT05100160 -
Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
|
Phase 3 | |
Completed |
NCT03229473 -
Fall Risk Assessment in COPD
|
||
Recruiting |
NCT04767074 -
A Non-pharmacological Cough Control Therapy
|
N/A | |
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT04996693 -
On Dose Efficiency of Modern CT-scanners in Chest Scans
|
N/A | |
Recruiting |
NCT04996173 -
Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)
|
N/A | |
Completed |
NCT04601545 -
The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method
|
N/A | |
Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
Recruiting |
NCT02862418 -
Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)
|